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Copyright © 2008 JCBN Summary γ-Tocopherol, the major form of dietary vitamin E, is absorbed in the intestine and
is secreted in chylomicrons, which are then transferred to liver lysosomes. Most γ-tocopherol
is transferred to liver microsomes and is catabolized by cytochrome p450. Due to the hydro-
phobicity of γ-tocopherol, a binding and transfer protein is plausible, but none have yet been
isolated and characterized. We recently found that a ubiquitous cytosolic protein, saposin B,
binds and transfers coenzyme Q10 (CoQ10), which is an essential factor for ATP production
and an important antioxidant. Here, we report that saposin B also binds γ-tocopherol, but not
α-tocopherol, as efficiently as CoQ10 at pH 7.4. At acidic pH, saposin B binds γ-tocopherol
preferentially to CoQ10 and α-tocopherol. Furthermore, we confirmed that saposin B selectively
binds γ-tocopherol instead of CoQ10 and α-tocopherol at every pH between 5.4 and 8.0 when
all three lipids are competing for binding. We detected γ-tocopherol in human saposin B mono-
clonal antibody-induced immunoprecipitates from human urine, although the amount of γ-
tocopherol was much smaller than that of CoQ10. These results suggest that saposin B binds
and transports γ-tocopherol in human cells.
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Introduction
Vitamin E was discovered as a dietary factor that is
essential for reproduction in 1922 [1]. It occurs as 4
tocopherols (α, β, γ, and δ) and 4 tocotrienols (α, β, γ, and
δ), of which α-tocopherol (α-Toc) has the highest biological
activity [2, 3]. In addition to α-Toc, γ-tocopherol (γ-Toc) is
an abundant tocopherol in our diet and both tocopherols
are taken up equally by the intestine and are secreted in
chylomicrons together with triglyceride and cholesterol [4,
5]. Both tocopherols are transferred to peripheral tissues
such as muscle and adipose during the lipoprotein lipase-
dependent catabolism of chylomicrons [6]. The resulting
chylomicron remnants are subsequently taken up by the liver
and disassembled in lysosomes [5]. α-Toc is preferentially
associated with α-Toc transfer protein (α-TTP) and is then
secreted in very low density lipoprotein (VLDL) [5,  7].
VLDL is converted to LDL in circulation. Since all tissues
have LDL receptors, α-Toc in LDL is thus transferred
throughout the body. On the other hand, γ-Toc in liver
lysosomes is transferred to the bile duct and is secreted in
bile [5], or to microsomes where it is degraded to 2,7,8-
trimethyl-2-(2'-carboxyethyl)6-hydroxychroman (γ-CEHC)G. Jin et al.
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[8] by cytochrome P450 [9, 10] and excreted in urine [8, 11].
Consequently, plasma and tissue concentrations of γ-Toc are
much smaller than those of α-Toc [3].
The most important physiological role of vitamin E is
thought to be as an antioxidant [2, 3], inhibiting free radical
oxidation of lipids. The antioxidant activity of γ-Toc is
smaller than that of α-Toc [12]. Because of this observation,
and its much lower concentrations when compared with α-
Toc, γ-Toc has been scarcely studied. However, γ-CEHC, a
γ-Toc metabolite, is natriuretic [8, 11]. Moreover, both γ-Toc
and γ-CEHC, but not α-Toc, inhibit cyclooxygenase activity
and, thus, possess anti-inflammatory properties [13]. These
findings have drawn more attention to γ-Toc.
One of the unsolved issues related to γ-Toc is its carrier
protein, as it is insoluble to water. We recently found that a
ubiquitous cytosolic protein, saposin B, binds and transfers
coenzyme Q10 (CoQ10) [14], which is an essential lipid
for ATP production in the mitochondria and an important
antioxidant in every biomembrane. Saposin B is a heat-
stable glycoprotein comprising 80 amino acids and a
carbohydrate component (molecular weights, 9100 and
3000, respectively), having a total molecular weight of
12.1 kDa [15]. Saposin B is known to bind sphingolipids
including ganglioside and ceramide [15], as well as glycero-
phospholipids such as phosphatidylcholine and phosphati-
dylinositol [16]. This occurs because saposin B is present as
a shell-like dimer [17] possessing a hydrophobic cavity for
lipid binding. We also found that saposin B binds CoQ10,
and that the saposin B-CoQ10 complex is present in human
cells such as sperm and the hepatoma cell line HepG2 [14].
During the course of our study on lipid affinity to saposin B,
we found it binds γ-Toc as efficiently as CoQ10. Here, we
discuss the possibility that saposin B is a binding/transfer
protein for γ-Toc.
Materials and Methods
Chemicals
CoQ10 was a generous gift from Kaneka (Osaka, Japan).
Coenzyme Q7 (CoQ7), α-Toc, and γ-Toc were kindly pro-
vided by Eisai (Tokyo, Japan). Methanol and 2-propanol
were of the highest grade commercially available.
Lipid analysis
Concentrations of CoQ10, CoQ7, α-Toc and γ-Toc were
determined using an HPLC system with an electrochemical
detector (ECD), as reported previously [18], with minor
modification. Briefly, samples were added to a 9-fold
volume of HPLC grade 2-propanol, vigorously mixed and
centrifuged. Supernatants thus obtained were injected onto
the HPLC-ECD system. Mobile phase: 50 mM NaClO4 in
methanol/2-propanol (7/3, v/v); flow rate: 1.0 ml/min;
analytical column: KANTO RP-18 (L) GP, 5 μm × 150 mm
× 4.6 mm (Kanto Chemical, Tokyo, Japan); post-reduction
column: RC-10, 15 mm × 4 mm (IRICA, Kyoto, Japan);
detector: ECD (600 mV) NANOSPACE SI-1 (Shiseido,
Tokyo, Japan).
Preparation of saposin B
Saposin B containing CoQ10 was purified as described
previously [14]. CoQ10-free saposin B was prepared by
mixing an aqueous solution with a 10-fold volume of hexane
followed by centrifugation.
Lipid binding assay
CoQ10-free saposin B (0.5 μM) in 50 mM phosphate
buffer (pH 7.4) containing 150 mM NaCl was vigorously
mixed for 5 min with hexane containing 10 mM lipids, such
as CoQ10, CoQ7, α-Toc and γ-Toc, followed by centrifuga-
tion at 1,600 × g for 10 min. Hexane was removed and the
aqueous layer was further centrifuged in Eppendorf-tubes at
15,000 × g for 10 min to separate contaminating hexane.
Lipid concentrations in the aqueous layer were analyzed by
HPLC-ECD. To investigate the pH dependence of the above
lipids binding to saposin B, 50 mM phosphate buffer
(pH 5.4, 6.4, 7.4 or 8.0) was employed. Saposin B-free
buffers were used as blanks.
Immunoprecipitation
Samples placed in Protein LoBind Tubes (Eppendorf,
Hamburg, Germany) were incubated with 5 μg of anti-
saposin B IgG or mouse normal IgG for 1 h at room
temperature. After incubation, 10 μl of protein G beads
(Amersham Biosciences, Uppsala, Sweden) were added to
samples, followed by further incubation for 1 h. Beads were
washed three times with PBS. Lipids were extracted from
beads with 2-propanol, followed by HPLC-ECD analysis.
SDS-PAGE sample buffer was mixed with beads and was
then subjected to Western blotting analysis of saposin B.
Western blotting
Saposin B was detected by Western blotting, as reported
previously [14]. Briefly, samples were separated by electro-
phoresis using an SDS/polyacrylamide gel (15% acryl-
amide). After electrophoresis, gels were stained with silver
staining kits (ATTO, Tokyo, Japan). For Western blotting
analysis, proteins were transferred to PVDF membranes,
which were then incubated with mouse anti-saposin B IgG
for 1 h at room temperature. Proteins were visualized using
HRP-conjugated secondary antibodies (Bio-Rad Japan,
Tokyo, Japan).
Statistical analyses
Data were analyzed by Student t test and values are means ±
SD. *, ** and *** indicate significant differences (p<0.05,
0.01 and 0.001, respectively) between the two groups.γ-Tocopherol Binding Protein
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Results and Discussion
Binding specificity of lipids to saposin B
The chemical structures of CoQ10, CoQ7, α-Toc, and γ-
Toc are shown in Fig. 1. We compared the binding affinities
of these lipids to saposin B by independently incubating
10 mM hexane solutions with aqueous CoQ10-free saposin
B (0.5 μM) solution (pH 7.4) for 5 min, and then analyzing
lipid contents in aqueous saposin B solution. Fig. 2 shows
the binding affinity of lipids, which decreases in the order of
CoQ10>CoQ7>>α-Toc, thus suggesting that tail length is an
important factor in determining binding affinity. It is there-
fore surprising that saposin B binds γ-Toc as efficiently as
CoQ10 (Fig. 2) despite, the much shorter tail length of γ-
Toc. Saposin B binds γ-Toc much more strongly than α-Toc
(Fig. 2), suggesting that the methyl group at the C-5 position
of α-Toc interferes with binding to saposin B. These results
suggest that saposin B has a binding site for γ-Toc.
We next examined the pH dependence of binding of the
three lipids (CoQ10, α-Toc and γ-Toc) to saposin B. Buffers
at pH 5.4, 6.4, 7.4 and 8.0 were employed. Binding affinities
of γ-Toc and α-Toc remained unchanged, irrespective of pH,
and the former had greater affinity than the latter (Fig. 3),
thus confirming the stronger affinity of γ-Toc when com-
pared with α-Toc. On the other hand, binding affinity of
CoQ10 to saposin B increased with pH, before leveling off at
neutral and alkaline pH levels (Fig. 3), thus suggesting that
binding affinity of saposin B for γ-Toc is greater than that for
CoQ10 at acidic pH. As the isoelectric point (pI) of saposin
B is 4.6 [15], at alkaline pH the hydrophobic cavity for lipid
binding may become larger because of electric repulsion of
carboxylic anions, and therefore binding of CoQ10 to
saposin B also becomes more favorable. In contrast, the
binding of γ-Toc to saposin B was independent of pH, which
indicates a specific binding site for γ-Toc in saposin B.
However, further investigation is required.
Fig. 1. Chemical structures of CoQ10, CoQ7, α-Toc, and γ-Toc.
Fig. 2. Binding affinity of CoQ10, CoQ7, α-Toc, and γ-Toc to
saposin B. Each lipid (10 mM) in hexane solution was
incubated independently with aqueous 0.5 μM saposin B
(pH = 7.4) for 5 min and amounts of lipids bound to
saposin B were measured. All experiments were repeat-
ed 3–6 times and means ± SD are shown. * and *** indi-
cate significant differences (p<0.05 and 0.001, respec-
tively) compared to values for γ-Toc. NS: not significant.G. Jin et al.
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Binding competition between two lipids
The above results prompted us to examine the binding
competition between the lipids instead of independently
measuring their binding affinities. γ-Toc and α-Toc were
selected for the first competition. A 10 mM hexane solution
of the two lipids was mixed with an aqueous saposin B
(0.5 μM) solution (pH 7.4) and the resulting aqueous
saposin B-bound lipids were measured. As expected, γ-Toc
was preferentially associated to saposin B (Fig. 4A). In the
competition between CoQ10 and γ-Toc at pH 7.4, saposin B
unexpectedly bound γ-Toc in preference to CoQ10
(Fig. 4B), as the independent binding affinities of the two
lipids were similar (Fig. 2). Moreover, α-Toc bound to
saposin B in preference to CoQ10 (Fig. 4C), despite of the
fact that saposin B affinity for α-Toc was much smaller than
that for CoQ10 (Fig. 2). It has been reported that saposin B
dimer binds more than one molecule of ganglioside [15] or
one molecule of phosphatidylinositol plus one molecule of
phosphatidylcholine or ganglioside GM1 [16]. As the
molecular size of CoQ10 is similar to that of phospholipids,
such as phosphatidylinositol and phosphatidylcholine, or the
hydrophobic part of ganglioside, and is twice that of
tocopherol, it is reasonable to assume that saposin B dimer
has capacity to bind two molecules of CoQ10 or one
molecule of CoQ10 plus two molecules of tocopherol.
Therefore, our results suggest that association of one
molecule of CoQ10 to saposin B dimer accelerates the
binding of two molecules of α-Toc, rather than the associa-
tion of an additional CoQ10 molecule. Binding of γ-Toc was
more favorable than α-Toc, as shown in Fig. 4A, as saposin
B is likely to have a specific binding site for γ-Toc. This is
consistent with our other results, but further experiments are
needed for confirmation.
Binding competition among CoQ10, α-Toc, and γ-Toc
The binding competition results for two lipids (Fig. 4)
predict that binding affinity to saposin B will decrease in the
order of γ-Toc>CoQ10 ≈α -Toc when the three lipids are all
competing for binding. To confirm this, all three lipids at
10 mM in hexane solution were mixed with an aqueous
saposin B solution at pH 5.4, 6.4, 7.4 or 8.0, and bound
lipids to saposin B were quantitated. We confirmed that
saposin B binds with γ-Toc significantly better than with
CoQ10 and α-Toc at all pH levels tested (Fig. 5), indicating
that γ-Toc is favored by saposin B. However, tissue concen-
trations of γ-Toc are much smaller than those of α-Toc and
CoQ10, as discussed below.
In vivo binding of γ-Toc to saposin B
Saposin B is a housekeeping protein necessary for lyso-
somal sphingolipid hydrolysis, and is therefore present in all
tissues [15]. To confirm the presence of the γ-Toc-saposin B
complex  in vivo, we performed an immunoprecipitation
experiment using monoclonal antibody against human
Fig. 3. Effects of buffer pH on binding of CoQ10, α-Toc, and γ-
Toc to saposin B. Each lipid (10 mM) in hexane solution
was incubated independently with aqueous 0.5 μM
saposin B for 5 min. All experiments were repeated 3–6
times and means ± SD are shown. *, **, and *** indi-
cate significant differences (p<0.05, 0.01 and 0.001,
respectively) compared to values for γ-Toc. NS: not
significant.
Fig. 4. Saposin B binding competition between (A) α-Toc and
γ-Toc, (B) CoQ10 and γ-Toc, and (C) CoQ10 and α-Toc.
Each lipid pair (10 mM) in hexane solution was incubated
with aqueous 0.5 μM saposin B (pH = 7.4) for 5 min. All
experiments were repeated 2–3 times and means ± SD
are shown. ** indicates a significant difference (p<0.01)
between the two groups.γ-Tocopherol Binding Protein
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saposin B. Fig. 6 shows that saposin B in human urine bound
considerable amounts of CoQ10, α-Toc, and γ-Toc. The
amounts increased in the order of γ-Toc<α-Toc<<CoQ10,
with their ratio being 1/5.7/1320. This order is in contrast to
the binding affinity of these lipids to saposin B decreases;
γ-Toc>>α-Toc, CoQ10 (Fig. 5). But this is not surprising
because amount of lipids bound to saposin B in vivo reflect
the concentration of lipids in tissues. In fact, the reported
molar ratios of γ-Toc/α-Toc/CoQ are 1/540/1580, 1/127/
1515, 1/63/1214, and 1/73/309 in mouse brain, heart, kidney
and liver, respectively [19]. Unfortunately human tissue data
are not available. If we assume that the molar ratio of the
three lipids in human kidney is similar to that in mouse
kidney (1/63/1214) and compare it with the molar ratio of
saposin B bound to the three lipids in human urine (1/5.7/
1350), we can conclude that human saposin B favors γ-Toc
and CoQ10 as binding lipids, but not α-Toc, in vivo.
In summary, we demonstrated for the first time that
human saposin B binds γ-Toc as well as CoQ10. Saposin B
is thus thought to play an important role in transferring γ-Toc
from liver lysosomes to microsomes, where it is metabolized
to γ-CEHC, or to the bile duct.
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